• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

National Standard (India) Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
504882
INE166R01015
141
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATIONSTD
246.28
2379.1
EPS(TTM)
Face Value()
Div & Yield %
4.83
10
0
 

Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter
May 27,2026
Net profit of Medicamen Biotech rose 59.50% to Rs 3.86 crore in the quarter ended March 2026 as against Rs 2.42 crore during the previous quarter ended March 2025. Sales rose 104.83% to Rs 60.65 crore in the quarter ended March 2026 as against Rs 29.61 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.58% to Rs 9.64 crore in the year ended March 2026 as against Rs 7.11 crore during the previous year ended March 2025. Sales rose 21.67% to Rs 197.77 crore in the year ended March 2026 as against Rs 162.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales60.6529.61 105 197.77162.55 22
OPM %8.97-5.44 -9.918.53 -
PBDT6.792.97 129 19.2016.95 13
PBT5.062.49 103 11.989.88 21
NP3.862.42 60 9.647.11 36